Kuros Biosciences AG (SW:KURN) — Stock Price
Kuros Biosciences AG (SW:KURN) is currently trading at CHF22.40 CHF, down 2.86% today. Over the past 52 weeks, shares have ranged between CHF17.79 and CHF33.36. This page tracks Kuros Biosciences AG's live share price on the SW exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see KURN company net worth.
Kuros Biosciences AG (KURN) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Kuros Biosciences AG's daily closing share price and trading volume on the SW exchange over the past year, giving a clear view of recent price momentum and liquidity.
Kuros Biosciences AG Income Statement — Revenue, Profit & Earnings by Year
Kuros Biosciences AG's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | CHF121.30 Million | CHF75.56 Million | CHF33.56 Million | CHF17.99 Million | CHF13.81 Million |
| Cost of Revenue | CHF16.51 Million | CHF13.52 Million | CHF9.63 Million | CHF7.22 Million | CHF3.75 Million |
| Gross Profit | CHF104.79 Million | CHF62.03 Million | CHF23.94 Million | CHF10.77 Million | CHF10.07 Million |
| Research & Development | CHF8.86 Million | CHF6.98 Million | CHF2.03 Million | CHF5.19 Million | CHF4.99 Million |
| SG&A | CHF81.63 Million | CHF5.08 Million | CHF8.45 Million | CHF3.07 Million | CHF2.58 Million |
| Total Operating Expenses | CHF97.47 Million | CHF67.03 Million | CHF38.09 Million | CHF24.21 Million | CHF18.83 Million |
| Operating Income | CHF7.33 Million | CHF-5.00 Million | CHF-13.19 Million | CHF-13.45 Million | CHF-8.77 Million |
| EBITDA | CHF10.13 Million | CHF-561.00K | CHF-6.84 Million | CHF-8.84 Million | CHF-5.29 Million |
| EBIT | CHF7.33 Million | CHF-3.20 Million | CHF-9.59 Million | CHF-11.67 Million | CHF-8.17 Million |
| Interest Expense | CHF304.79K | CHF149.00K | CHF186.00K | CHF4.32 Million | CHF1.38 Million |
| Income Before Tax | CHF4.16 Million | CHF-3.35 Million | CHF-9.78 Million | CHF-15.99 Million | CHF-9.55 Million |
| Income Tax Expense | CHF2.12 Million | CHF370.00K | CHF380.00K | CHF-1.40 Million | CHF-2.01 Million |
| Net Income | CHF2.12 Million | CHF-3.72 Million | CHF-13.73 Million | CHF-14.60 Million | CHF-7.54 Million |
Kuros Biosciences AG Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Kuros Biosciences AG's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | CHF107.21 Million | CHF84.54 Million | CHF71.46 Million | CHF82.95 Million | CHF91.34 Million |
| Total Current Assets | CHF65.49 Million | CHF44.75 Million | CHF27.19 Million | CHF31.39 Million | CHF32.89 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | CHF342.00K | — | — |
| Net Receivables | CHF31.85 Million | CHF14.93 Million | CHF7.62 Million | CHF3.62 Million | CHF1.88 Million |
| Inventory | CHF16.92 Million | CHF9.44 Million | CHF4.86 Million | CHF3.17 Million | CHF1.76 Million |
| Property, Plant & Equipment | CHF4.68 Million | CHF3.72 Million | CHF3.25 Million | CHF2.32 Million | CHF2.45 Million |
| Goodwill | CHF19.25 Million | CHF19.43 Million | CHF24.47 Million | CHF29.31 Million | CHF33.39 Million |
| Total Liabilities | CHF40.28 Million | CHF25.79 Million | CHF14.75 Million | CHF14.09 Million | CHF14.36 Million |
| Total Current Liabilities | CHF33.39 Million | CHF20.90 Million | CHF13.19 Million | CHF12.59 Million | CHF11.29 Million |
| Long-term Debt | CHF3.58 Million | CHF3.88 Million | CHF4.15 Million | — | — |
| Net Debt | CHF-11.72 Million | CHF-15.67 Million | CHF-12.06 Million | CHF-22.15 Million | CHF-19.70 Million |
| Total Stockholder Equity | CHF66.93 Million | CHF58.75 Million | CHF56.71 Million | CHF68.86 Million | CHF76.98 Million |
| Retained Earnings | CHF-29.94 Million | CHF-45.43 Million | CHF-42.15 Million | CHF-116.25 Million | CHF-101.17 Million |
Kuros Biosciences AG Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Kuros Biosciences AG generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | CHF-377.87K | CHF3.14 Million | CHF-8.84 Million | CHF-7.35 Million | CHF-5.45 Million |
| Capital Expenditures | CHF2.03 Million | CHF1.11 Million | CHF326.00K | CHF400.00K | CHF374.00K |
| Free Cash Flow | CHF-2.40 Million | CHF2.03 Million | CHF-9.17 Million | CHF-7.75 Million | CHF-5.83 Million |
| Investing Cash Flow | CHF-2.03 Million | CHF-1.11 Million | CHF-326.00K | CHF-400.00K | CHF-374.00K |
| Financing Cash Flow | CHF1.17 Million | CHF1.34 Million | CHF-171.00K | CHF3.22 Million | CHF6.08 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | CHF4.20 Million | CHF5.13 Million | CHF917.00K | CHF1.03 Million | CHF389.00K |
| Depreciation | CHF2.80 Million | CHF2.58 Million | CHF2.75 Million | CHF2.83 Million | CHF2.88 Million |
| Change in Cash | CHF-2.36 Million | CHF3.81 Million | CHF-9.86 Million | CHF-4.56 Million | CHF241.00K |
Kuros Biosciences AG Earnings History — EPS Actual vs. Analyst Estimates
Track Kuros Biosciences AG's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Aug 13, 2026 | — | — | — |
| Mar 10, 2026 | — | — | — |
| Oct 16, 2025 | 0.00 | 0.00 | — |
| Aug 14, 2025 | -0.05 | — | — |
| Apr 15, 2025 | -0.01 | 0.00 | — |
| Mar 12, 2025 | 0.00 | 0.00 | — |
| Oct 10, 2024 | 0.00 | 0.00 | — |
| Aug 07, 2024 | -0.01 | 0.00 | — |